ArticleACS nano2023

Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma.

Xiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.